Colgate Palmolive Co (CL) stock
CLNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 10/3030% above fair value
$99.61−1.38 (-1.37%)
Close on Nov 17, 2026Market cap $79.18BP/E 39.1Yield 2.09%
Colgate Palmolive operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Colgate Palmolive's operating income for the twelve months ending Sep 30, 2026 was $3.16B, down 26.1% year over year. For fiscal 2025 it was $3.31B, down 22.5% from the year before. Over ten years it grew 1.7% a year on average. The highest annual figure on record is $4.27B in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.31B | -22.5% |
| FY2024 | Dec 31, 2024 | $4.27B | +7.1% |
| FY2023 | Dec 31, 2023 | $3.98B | +37.7% |
| FY2022 | Dec 31, 2022 | $2.89B | -13.2% |
| FY2021 | Dec 31, 2021 | $3.33B | -14.2% |
| FY2020 | Dec 31, 2020 | $3.89B | +9.3% |
| FY2019 | Dec 31, 2019 | $3.55B | -3.8% |
| FY2018 | Dec 31, 2018 | $3.69B | -0.4% |
| FY2017 | Dec 31, 2017 | $3.71B | -6.3% |
| FY2016 | Dec 31, 2016 | $3.96B | +41.8% |
| FY2015 | Dec 31, 2015 | $2.79B | -21.6% |
| FY2014 | Dec 31, 2014 | $3.56B | +0.0% |
| FY2013 | Dec 31, 2013 | $3.56B | -8.6% |
| FY2012 | Dec 31, 2012 | $3.89B | +1.2% |
| FY2011 | Dec 31, 2011 | $3.84B | +10.1% |
| FY2010 | Dec 31, 2010 | $3.49B | -3.5% |
| FY2009 | Dec 31, 2009 | $3.62B | +16.6% |
| FY2008 | Dec 31, 2008 | $3.10B | +14.0% |
| FY2007 | Dec 31, 2007 | $2.72B | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.09B | +2.7% |
| Q2 FY2026 | Jun 30, 2026 | $1.02B | -5.9% |
| Q1 FY2026 | Mar 31, 2026 | $964.00M | -10.4% |
| Q4 FY2025 | Dec 31, 2025 | $92.00M | -91.3% |
| Q3 FY2025 | Sep 30, 2025 | $1.06B | -0.6% |
| Q2 FY2025 | Jun 30, 2025 | $1.08B | -1.1% |
| Q1 FY2025 | Mar 31, 2025 | $1.08B | +2.8% |
| Q4 FY2024 | Dec 31, 2024 | $1.06B | -0.8% |
| Q3 FY2024 | Sep 30, 2024 | $1.07B | +3.5% |
| Q2 FY2024 | Jun 30, 2024 | $1.09B | +12.1% |
| Q1 FY2024 | Mar 31, 2024 | $1.05B | +15.2% |
| Q4 FY2023 | Dec 31, 2023 | $1.07B | +430.7% |
| Q3 FY2023 | Sep 30, 2023 | $1.03B | +8.7% |
| Q2 FY2023 | Jun 30, 2023 | $974.00M | +10.2% |
| Q1 FY2023 | Mar 31, 2023 | $909.00M | +5.7% |
| Q4 FY2022 | Dec 31, 2022 | $202.00M | -44.7% |
| Q3 FY2022 | Sep 30, 2022 | $947.00M | -2.1% |
| Q2 FY2022 | Jun 30, 2022 | $884.00M | -11.2% |
| Q1 FY2022 | Mar 31, 2022 | $860.00M | -14.3% |
| Q4 FY2021 | Dec 31, 2021 | $365.00M | -62.3% |
| Q3 FY2021 | Sep 30, 2021 | $967.00M | -5.0% |
| Q2 FY2021 | Jun 30, 2021 | $996.00M | +5.3% |
| Q1 FY2021 | Mar 31, 2021 | $1.00B | +5.5% |
| Q4 FY2020 | Dec 31, 2020 | $969.00M | +4.1% |
| Q3 FY2020 | Sep 30, 2020 | $1.02B | +18.9% |
| Q2 FY2020 | Jun 30, 2020 | $946.00M | +6.5% |
| Q1 FY2020 | Mar 31, 2020 | $952.00M | +8.3% |
| Q4 FY2019 | Dec 31, 2019 | $931.00M | +4.5% |
| Q3 FY2019 | Sep 30, 2019 | $856.00M | -2.1% |
| Q2 FY2019 | Jun 30, 2019 | $888.00M | -6.1% |
| Q1 FY2019 | Mar 31, 2019 | $879.00M | -10.6% |
| Q4 FY2018 | Dec 31, 2018 | $891.00M | -7.2% |
| Q3 FY2018 | Sep 30, 2018 | $874.00M | -8.7% |
| Q2 FY2018 | Jun 30, 2018 | $946.00M | +7.7% |
| Q1 FY2018 | Mar 31, 2018 | $983.00M | +7.8% |
| Q4 FY2017 | Dec 31, 2017 | $960.00M | -10.5% |
| Q3 FY2017 | Sep 30, 2017 | $957.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $878.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $912.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.07B | – |
See a number that looks wrong?